ezogabine has been researched along with colforsin in 1 studies
| Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (colforsin) | Trials (colforsin) | Recent Studies (post-2010) (colforsin) |
|---|---|---|---|---|---|
| 383 | 26 | 241 | 13,460 | 46 | 1,298 |
| Protein | Taxonomy | ezogabine (IC50) | colforsin (IC50) |
|---|---|---|---|
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 1.729 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.041 | |
| Adenylate cyclase type 1 | Homo sapiens (human) | 0.0955 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hill, MA; Lee, S; Li, M; Tanner, MA; Yang, Y | 1 |
1 other study(ies) available for ezogabine and colforsin
| Article | Year |
|---|---|
Heterogeneity in Kv7 channel function in the cerebral and coronary circulation.
Topics: Animals; Basilar Artery; Carbamates; Cerebrovascular Circulation; Circle of Willis; Colforsin; Coronary Circulation; Indoles; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Male; Mice; Mice, Knockout; Muscle Contraction; Muscle, Smooth, Vascular; Organ Specificity; Phenylenediamines; Potassium Channel Blockers; Pyridines; Vasoconstriction; Vasodilation; Vasodilator Agents | 2015 |